Fennec Pharmaceuticals (FENC) vs Turn Therapeutics (TTRX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Turn Therapeutics (TTRX) has outperformed Fennec Pharmaceuticals (FENC) over the past year, gaining 72.9% versus a gain of 9.3%. Turn Therapeutics is the larger company by market cap ($367.4 million vs $363.3 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | FENC | TTRX |
|---|---|---|
| Share price | $10.36 | $12.10 |
| Market cap | $363.30M | $367.45M |
| 1-day change | +0.10% | +3.95% |
| YTD return | +34.55% | +207.11% |
| 1-year return | +9.28% | +72.86% |
| 5-year return | +12.73% | — |
| Forward P/E | 10.93 | — |
| EPS (TTM) | $-0.12 | $-0.29 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $13.25 | $26.50 |
| 52-week low | $5.65 | $2.57 |
| Distance from 52-week high | -21.81% | -54.34% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +70.56% | +106.61% |
| Average volume | 194.30K | 114.62K |
| Shares outstanding | 35.07M | 30.37M |
| Employees | 35 | 2 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- TTRX has outperformed FENC by 63.6 percentage points over the past year.
About Fennec Pharmaceuticals
FENC stock →Fennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 35 employees
About Turn Therapeutics
TTRX stock →Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses.
Health Care · Biotechnology: Pharmaceutical Preparations · 2 employees
FENC vs TTRX FAQ
Which is bigger, Fennec Pharmaceuticals or Turn Therapeutics?
Turn Therapeutics (TTRX) is larger, with a market capitalization of $367.45M compared with $363.30M for Fennec Pharmaceuticals (FENC).
Which stock has performed better over the past year, FENC or TTRX?
TTRX returned +72.86% over the past 12 months, compared with +9.28% for FENC (price return, excluding dividends). Past performance does not predict future results.
Are Fennec Pharmaceuticals and Turn Therapeutics in the same industry?
Both are in the Health Care sector, but in different industries: Biotechnology: Biological Products (No Diagnostic Substances) for Fennec Pharmaceuticals and Biotechnology: Pharmaceutical Preparations for Turn Therapeutics.